Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Bile Duct Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Early research (Phase 1)Not Yet RecruitingNCT07131540
What this trial is testing

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)

Who this might be right for
Acute-On-Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 10
Large-scale testing (Phase 3)Study completedNCT02600325
What this trial is testing

Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV

Who this might be right for
Acute Hepatitis CHuman Immunodeficiency VirusHepatitis C
Erasmus Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT02174276
What this trial is testing

Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 195
Testing effectiveness (Phase 2)Looking for participantsNCT06863376
What this trial is testing

Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Tanta University 46
Not applicableStudy completedNCT05406089
What this trial is testing

Effects of Antiviral Therapy on Patients With HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaHepatitis B VirusSurvival
First Affiliated Hospital Xi'an Jiaotong University 494
Not applicableLooking for participantsNCT07224750
What this trial is testing

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)+3 more
City of Hope Medical Center 1,000
Testing effectiveness (Phase 2)Study completedNCT04134091
What this trial is testing

The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Lipocine Inc. 56
Not applicableUnknownNCT06117735
What this trial is testing

Clinical Study of PTFE Covered Stent for Treating Portal Hypertension

Who this might be right for
Portal Hypertension
Enlight Medical Technologies (Shanghai) Co., Ltd 177
Large-scale testing (Phase 3)Study completedNCT00036608
What this trial is testing

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb
Not applicableUnknownNCT06020976
What this trial is testing

Pattern of Autoimmune Hepatitis in Children In Sohag University Hospital

Who this might be right for
Autoimmune Hepatitis
Sohag University 20
Not applicableUnknownNCT03074708
What this trial is testing

Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic Surgery

Who this might be right for
Liver DiseasesPancreatic DiseasesBiliary Tract Diseases
Zhujiang Hospital 200
Large-scale testing (Phase 3)WithdrawnNCT01517308
What this trial is testing

24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C

Who this might be right for
Chronic Hepatitis C
Federico II University
Large-scale testing (Phase 3)WithdrawnNCT00381017
What this trial is testing

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Who this might be right for
Hepatitis CLiver CirrhosisHIV Infections
Merck Sharp & Dohme LLC
Very early researchEnded earlyNCT04150874
What this trial is testing

Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
H. Lee Moffitt Cancer Center and Research Institute 4
Not applicableUnknownNCT06369597
What this trial is testing

Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery

Who this might be right for
Liver CancerRenal CancerRectal Cancer
Sun Yat-sen University 177
Not applicableStudy completedNCT04597710
What this trial is testing

Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing

Who this might be right for
Liver CancerLiver Metastasis Colon Cancer
Perspectum 200
Large-scale testing (Phase 3)Study completedNCT01854697
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 311
Testing effectiveness (Phase 2)Study completedNCT01180790
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Who this might be right for
Hepatitis C
Alexion Pharmaceuticals, Inc. 122
Testing effectiveness (Phase 2)Study completedNCT02117713
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc. 34
Next Page